Klinik fanlar yilnomasi Ҷилди 1 № 3 (2024)
MODERN TREATMENT PRINCIPLES OF ANEMIA IN CHRONIC HEART FAILURE
Хужакулова Ф.И, Гадаев А.Г, Нуритдинов Н.А
Аннотатсия
The study comparatively examined the impact of standard therapy, including dapagliflozin, a type 2 sodium glucose cotransporter inhibitor, on hematological changes and intracardiac hemodynamics in patients with anemia and chronic heart failure. The increase in erythropoietin levels in the group of patients receiving dapagliflozin after treatment is associated with the drug's stimulating effect on erythropoietin production in the kidneys.
chronic heart failure, dapagliflozin, anemia, ferritinхроническая сердечная недостаточность, дапаглифлозин, анемия, ферритинсурункали юрак етишмовчилиги, дапаглифлозин, камқонлик, ферритин
Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.